Showing results (91-100 of 212) with videos related to
Sort By:
Pageof 22
The American Journal of Emergency Medicine|May 29, 2012
Therapy and outcomes in massive pulmonary embolism from the Emergency Medicine Pulmonary Embolism in the Real World RegistryBrian W Lin, Donald H Schreiber, Gigi Liu, et al.American Heart Journal|December 1, 2012
Design and rationale of the treatment of acute coronary syndromes with otamixaban trial: a double-blind triple-dummy 2-stage randomized trial comparing otamixaban to unfractionated heparin and eptifibatide in non-ST-segment elevation acute coronary syndromes with a planned early invasive strategyPhilippe Gabriel Steg, Shamir R Mehta, Charles V Pollack, et al.The American Journal of Cardiology|May 29, 2007
Patterns of aspirin dosing in non-ST-elevation acute coronary syndromes in the CRUSADE Quality Improvement InitiativeSumit Tickoo, Matthew T Roe, Eric D Peterson, et al.American Heart Journal|September 7, 2016
Apixaban compared with parenteral heparin and/or vitamin K antagonist in patients with nonvalvular atrial fibrillation undergoing cardioversion: Rationale and design of the EMANATE trialMichael D Ezekowitz, Charles V Pollack, Paul Sanders, et al.Journal of Interventional Cardiology|December 1, 2010
Acute coronary syndromes: from the emergency department to the catheterization laboratory-integrating evidence from recent ACS/NSTEMI trials into clinical practice: an evidence-based review of recent clinical trial results and report on a roundtable discussionRobert P Giugliano, Charles V Pollack, Gerard X Brogan, et al.Clinical Kidney Journal|May 3, 2024
Maintained renin-angiotensin-aldosterone system inhibitor therapy with sodium zirconium cyclosilicate following a hyperkalaemia episode: a multicountry cohort studyAnjay Rastogi, Charles V Pollack, Ignacio José Sánchez Lázaro, et al.Journal of Interventional Cardiology|August 30, 2008
Treatment strategies in non-ST-elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention: an evidence-based review of clinical trial results and treatment guidelines: report on a roundtable discussionMarc Cohen, James Hoekstra, Robert Giugliano, et al.Annals of Surgery|October 11, 2019
Dabigatran Reversal With Idarucizumab in Patients Requiring Urgent Surgery: A Subanalysis of the RE-VERSE AD StudyJerrold H Levy, Joanne van Ryn, Frank W Sellke, et al.American Heart Journal|October 27, 2009
Comparative trends in guidelines adherence among patients with non-ST-segment elevation acute coronary syndromes treated with invasive versus conservative management strategies: Results from the CRUSADE quality improvement initiativeEzra A Amsterdam, Eric D Peterson, Fang-Shu Ou, et al.Pharmacotherapy|May 30, 2009
Weight-based dosing of enoxaparin in obese patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE initiativeSarah A Spinler, Fang-Shu Ou, Matthew T Roe, et al.Pageof 22